What is the Impact Factor of Clinical Psychopharmacology and Neuroscience?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Clinical Psychopharmacology and Neuroscience is 3.40, ranking in quartile Q2 of Web of Science (SCIE).

Is Clinical Psychopharmacology and Neuroscience indexed in Web of Science or Scopus?

Yes, Clinical Psychopharmacology and Neuroscience is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.976 (Q1) and an H-index of 51.

Who publishes Clinical Psychopharmacology and Neuroscience and what is the Article Processing Charge (APC)?

Clinical Psychopharmacology and Neuroscience is published by Korean College of Neuropsychopharmacology. The estimated Article Processing Charge (APC) is approximately $3,227 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Clinical Psychopharmacology and Neuroscience?

The official ISO-4 abbreviation of Clinical Psychopharmacology and Neuroscience is "CLIN. PSYCHOPHARMACOL. NEUROSCI". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #5,088Hybrid

Clinical Psychopharmacology and Neuroscience

Abbreviation (ISO):CLIN. PSYCHOPHARMACOL. NEUROSCI

•

Identifier (ISSN):1738-1088(Print)

•

Publisher:Korean College of Neuropsychopharmacology

Official Website Submission Portal Compare

Clarivate IF (2026)

3.4↑ +0.7

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical Psychopharmacology and Neuroscience

WoS Q2

Annual Impact Factor Metric

Current (2026):3.4

Scopus SJR & RankScopus Q1

0.976

#5,088

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

51 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate16.7%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

82articles/year

99.56% Gold OA•87.18% Original Research

Aims & Scope

Clinical Psychopharmacology and Neuroscience (Clin Psychopharmacol Neurosci) launched in 2003, is the official journal of The Korean College of Neuropsychopharmacology (KCNP), and the associate journal for Asian College of Neuropsychopharmacology (AsCNP). This journal aims to publish evidence-based, scientifically written articles related to clinical and preclinical studies in the field of psychopharmacology and neuroscience. This journal intends to foster and encourage communications between psychiatrist, neuroscientist and all related experts in Asia as well as worldwide. It is published four times a year at the last day of February, May, August, and November.

Topics Covered (Recognized by AI)

Medicine99.3%Psychology96.7%Psychiatry91.8%Biology90.4%Internal medicine83.3%Neuroscience62.2%Endocrinology57.1%Computer science46%Clinical psychology45%Pathology40.9%Programming language39.9%Cognition39.8%Chemistry38.5%Schizophrenia (object-oriented programming)37.5%Genetics36%Biochemistry35.7%Pharmacology30.7%Social psychology29%Anxiety24.4%Mood23.9%Mathematics22.7%Economics21.1%Surgery20.4%

Primary Research Areas

Neurosciencespharmacology & Pharmacy Pharmacology & Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

NEUROSCIENCES

Rank144/330

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank143/356

IndexSCIE

JCISCIE2026

NEUROSCIENCES

Rank197/330

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank161/356

IndexSCIE

Category	Index	Rank	Quartile
NEUROSCIENCES	JCRSCIE	144/330	Q2
PHARMACOLOGY & PHARMACY	JCRSCIE	143/356	Q2
NEUROSCIENCES	JCISCIE	197/330	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	161/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.4

Articles / Year44

Total Citations1

2025

IF2.7

Articles / Year74

Total Citations65

2024

IF2.4

Articles / Year64

Total Citations237

2023

IF3.2

Articles / Year121

Total Citations1,157

2022

IF3.731

Articles / Year80

Total Citations876

Year	Impact Factor	Articles / Year	Total Citations
2026	3.4	44	1
2025	2.7	74	65
2024	2.4	64	237
2023	3.2	121	1,157
2022	3.731	80	876
2021	2.582	87	1,110
2020	2.567	74	1,738
2019	2.47	74	1,571
2018	2.09	93	1,598
2017	—	69	1,789
2016	—	68	1,556
2015	—	54	1,898

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,088Scopus Q1SCImago Profile

Scopus Coverage:2005-2026

•

Scopus Broad Areas:MedicineNeuroscience

Scopus Citation Rank (SJR)Q1

0.976

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

3.51

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,227 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations794

3-Year Documents240

Citable Documents233

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology (medical)Q1

Behavioral NeuroscienceQ2

Psychiatry and Mental HealthQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 16.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区NEUROSCIENCES

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical Psychopharmacology and Neuroscience (abbr: CLIN. PSYCHOPHARMACOL. NEUROSCI, ISSN: 1738-1088) is a peer-reviewed international scholarly journal in the field of NEUROSCIENCESPHARMACOLOGY & PHARMACY, published by Korean College of Neuropsychopharmacology in South Korea. The periodical holds a Journal Impact Factor (JIF) of 3.40, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.976 (Q1), an H-index of 51.

The journal enforces rigorous peer evaluation with an annual output of approximately 82 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,227 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.